StageZero Life Sciences Ltd T.SZLS

Alternate Symbol(s): SZLSF

Healthcare Biotechnology

StageZero Life Sciences, Ltd. is a Canada-based vertically integrated healthcare company. The Company is focused on improving the early detection and management of cancer and other chronic diseases through diagnostics telehealth programs. Its lead product, Aristotle, is a mRNA multi-cancer panel for simultaneously screening for multiple cancers from a single sample of blood with high sensitivity and specificity for each cancer. The Care Oncology Clinic offers a supervised treatment regimen for people diagnosed with cancer of any type or stage. AVRT is a physician-led, telehealth program for identifying and managing the early warning signs of cancer and chronic disease. Its program includes a comprehensive online health evaluation; bloodtests to measure markers of inflammation and metabolism; an initial physician consultation; regular physician follow-up appointments and interval screening. Its additional cancer diagnostics include ColonSentry and the Prostate Health Index.

TSX:SZLS - Post by User

StageZero Life Sciences Ltd

<< Previous

Bullboard Posts

Next >>

Post by tickertomon Sep 21, 2020 10:22am

165 Views

Post# 31590769

level 2 again

Number of Shares		Bid Price
9,000 shares	9,000	1.030
21,500 shares	21,500	1.010
17,500 shares	17,500	1.000
14,500 shares	14,500	0.990
18,000 shares	18,000	0.970
3,000 shares	3,000	0.960
22,500 shares	22,500	0.950
20,500 shares	20,500	0.940
5,000 shares	5,000	0.920
4,500 shares	4,500	0.900

Level two quotes - Ask
Ask Price	Number of Shares
1.050	3,000	3,000 shares
1.060	2,000	2,000 shares
1.070	4,500	4,500 shares
1.080	8,000	8,000 shares
1.090	12,500	12,500 shares
1.100	41,500	41,500 shares
1.110	3,000	3,000 shares
1.140	3,000	3,000 shares
1.150	12,000	12,000 shares
1.170	7,500